GHRS CIK: 1855129

GH Research PLC

  • Ireland
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−15.1
FY22:
−30.6
FY23:
−41.2
FY24:
−50.3
FY25:
−60.7
(positive)
millions USD
FY21:
−15.1
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.20
FY22:
−22.5
FY23:
−35.6
FY24:
−39.0
FY25:
−48.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.20
FY22:
−22.5
FY23:
−35.6
FY24:
−39.0
FY25:
−48.3

All amounts in millions USD Data sources:SEC EDGARTwelve Data